Yu CY - Search Results

1

Prevalence and risk factors for chronic kidney disease in patients with coronary artery disease.

Bao YS, Na SP, Jia XB, Liu RC, Wang MA, Yu CY, Mu SH, Xie RJ. Bao YS, et al. Among authors: yu cy. Curr Med Res Opin. 2012 Mar;28(3):379-84. doi: 10.1185/03007995.2012.661708. Epub 2012 Feb 16. Curr Med Res Opin. 2012. PMID: 22335251

2

Characterization of interleukin-33 and soluble ST2 in serum and their association with disease severity in patients with chronic kidney disease.

Bao YS, Na SP, Zhang P, Jia XB, Liu RC, Yu CY, Mu SH, Xie RJ. Bao YS, et al. Among authors: yu cy. J Clin Immunol. 2012 Jun;32(3):587-94. doi: 10.1007/s10875-011-9622-7. Epub 2011 Dec 28. J Clin Immunol. 2012. PMID: 22203232

3

Characterization of Lipoprotein-associated Phospholipase A2 in Serum in Patients With Stage 3-5 Chronic Kidney Disease.

Wang Y, Li SS, Na SP, Yu CY, Ji Y, Zhao SL, Xie RJ, Bao YS. Wang Y, et al. Among authors: yu cy. Am J Med Sci. 2016 Oct;352(4):348-353. doi: 10.1016/j.amjms.2016.07.002. Epub 2016 Jul 14. Am J Med Sci. 2016. PMID: 27776715

4

Relationship between hypoalbuminemia, hyperlipidemia and renal severity in patients with lupus nephritis: a prospective study.

Sui M, Jia X, Yu C, Guo X, Liu X, Ji Y, Mu S, Wu H, Xie R. Sui M, et al. Cent Eur J Immunol. 2014;39(2):243-52. doi: 10.5114/ceji.2014.43730. Epub 2014 Jun 27. Cent Eur J Immunol. 2014. PMID: 26155131 Free PMC article.

5

Epidemiology and risk factors for progression in Chinese patients with IgA nephropathy.

Liu Y, Wei W, Yu C, Xing L, Wang M, Liu R, Ma J, Liu X, Xie R, Sui M. Liu Y, et al. Med Clin (Barc). 2021 Sep 24;157(6):267-273. doi: 10.1016/j.medcli.2020.05.064. Epub 2020 Aug 18. Med Clin (Barc). 2021. PMID: 32826075 English, Spanish.

6

Associations between m-type phospholipase A2 receptor,human leukocyte antigen gene polymorphisms and idiopathic membranous nephropathy.

Liu X, Xu W, Yu C, Wang M, Liu R, Xie R. Liu X, et al. Bioengineered. 2021 Dec;12(1):8833-8844. doi: 10.1080/21655979.2021.1987080. Bioengineered. 2021. PMID: 34607530 Free PMC article.

7

[Effect of telmisartan on tubulointerstitial injury and expression of PPARγ in rat renal tissue of IgA nephropathy model].

Xing L, Bai L, Yu CY, Xie RJ. Xing L, et al. Among authors: yu cy. Zhonghua Yi Xue Za Zhi. 2010 Nov 2;90(40):2860-3. Zhonghua Yi Xue Za Zhi. 2010. PMID: 21162800 Chinese.

8

Original Research: Atorvastatin prevents rat cardiomyocyte hypertrophy induced by parathyroid hormone 1-34 associated with the Ras-ERK signaling.

Liu X, Zou C, Yu C, Xie R, Sui M, Mu S, Li L, Zhao S. Liu X, et al. Exp Biol Med (Maywood). 2016 Oct;241(16):1745-50. doi: 10.1177/1535370216649259. Epub 2016 May 10. Exp Biol Med (Maywood). 2016. PMID: 27190264 Free PMC article.

9

Phosphatidylserine on microparticles and associated cells contributes to the hypercoagulable state in diabetic kidney disease.

Yu M, Xie R, Zhang Y, Liang H, Hou L, Yu C, Zhang J, Dong Z, Tian Y, Bi Y, Kou J, Novakovic VA, Shi J. Yu M, et al. Nephrol Dial Transplant. 2018 Dec 1;33(12):2115-2127. doi: 10.1093/ndt/gfy027. Nephrol Dial Transplant. 2018. PMID: 29529237

10

Plasma sMer, sAxl and GAS6 levels correlate with disease activity and severity in lupus nephritis.

Gong S, Xu Z, Liu Y, Xing L, Ma J, Yu C, Liu X, Jia X, Xie R, Sui M. Gong S, et al. Eur J Clin Invest. 2019 Mar;49(3):e13064. doi: 10.1111/eci.13064. Epub 2019 Jan 11. Eur J Clin Invest. 2019. PMID: 30588607

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,183 results

Search Page

Filters